VP, CDMA TA Group Lead - Emerging Areas

BoehringerPRD•Brampton, ON

About The Position

The VP, Therapeutic Area Clinical Development and Medical Affairs (TA CDMA) group lead is responsible for ensuring that the assets under their Therapeutic Area (i.e., Mental Health, Eye Health, etc.) have the evidence, medical value proposition, and medical market preparation to ensure launch and post-launch success in the US market. As the medical leader for the Therapeutic Area, the group lead ensures that the strategy, evidence plan, tactical execution, and medical field teams are resourced and effective in reflecting what is needed for the US market. The group lead works closely with critical teams (medical excellence, Go-To-Market (GTM), Analytics & Insights (A&I), Corporate teams, Asset Teams, Real World Evidence (RWE), Marketing/market access, Clinical Development & Operations (CD&O), and others) to align and pull through the US medical strategy and execution. The VP, CDMA TA Group Lead directly leads resources that drive Medical Affairs US input in clinical development, US medical affairs strategy development, and US MSL teams for that TA. This role is responsible for driving the One CDMA/One Medicine/One Team vision. This role is a key contributor to the ongoing development of required Clinical Development and Medical Affairs capabilities required to continuously elevate the role and contributions of the US CDMA organization. As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.

Requirements

Master’s degree with a minimum of ten (10) years of proven clinical, academic, and business experience in a leadership position within Medical Affairs or equivalent.
Doctoral degree with a minimum of eight (8) years of proven clinical, academic, and business experience in a leadership position within Medical Affairs or equivalent.
MD with a minimum of six (6) years of proven clinical, academic, and business experience in a leadership position within Medical Affairs or equivalent, providing the MD has had previous people leadership experience.
Extensive strategy development and execution experience with Master’s / Doctoral Degree preferably in life sciences required, MD preferred.
Minimum of five (5) years' experience leading and developing people / scientific teams; experience in overseeing field-based teams desired.
Experience in both clinical development and medical affairs desired.
Strong communication and collaborative skills with the ability to coach and develop a team.
Proven ability to translate customer needs to a relevant therapeutic area strategy spanning across all available customer segments and channels.
Deep scientific knowledge of the US healthcare system and regulatory landscape, including the needs of providers, patients, payers, and caregivers across the US within the therapeutic area(s).
Ability to travel both domestic and internationally.
Must be legally authorized to work in the United States without restriction.
Must be willing to take a drug test and post-offer physical (if required).
Must be 18 years of age or older.

Nice To Haves

MD preferred.
experience in overseeing field-based teams desired.
Experience in both clinical development and medical affairs desired.

Responsibilities

Accountable for the development, cross-functional alignment, and delivery of the TA strategy.
Leads the Early Asset, Medical Strategy, and Medical Science Liaison teams ensuring the execution of the US Medical therapeutic area strategy, effective engagement with customers and stakeholders, and the coordinated input into global clinical development.
Responsible to ensure that the assets under their TA have the evidence, medical value proposition and medical market preparation to ensure launch and post launch success in the US market.
Drives development, contextualization, and application of scientific / medical / market / healthcare delivery expertise, therapeutic area-based strategies, and operational excellence for products, and pipeline compounds.
Works with RWE and Medical Excellence leaders to ensure the development, execution, and measurement of US market aligned customer engagement activities and clinical development interactions for BI products.
Responsible for the oversight of the US TA Early Assets Lead to ensure that US-specific considerations are prioritized and implemented in the strategic and tactical planning for clinical development.
Works with RWE, clinical development, HEOR, market access, and other cross-functional evidence generation teams to ensure the development and execution of a US market aligned integrated evidence plan. This role identifies evidence gaps and proposes evidence generation ideas that consider the healthcare patient outcome needs of the US healthcare ecosystem.
Serves as the key representative in cross-functional discussions with US and global internal stakeholders regarding therapeutic area specific processes, decisions, and product governance, specifically for the therapeutic areas, in-line product portfolio and relevant pipeline assets.
Manages consultations with the Medical Customer Experience, Grants, Sponsorships & Communications, and Medical Engagement, and Capability Excellence teams to co-create scientific narratives, identify clinically meaningful differentiators, and ensure insights and messaging generated for BI products are scientifically accurate.
Engages with key scientific stakeholders, US clinical development and operations, pipeline marketing, and asset teams to consult on Clinical Development strategy / execution, stakeholder engagement, data dissemination, treatment paradigms and trial logistics for BI products.
Accountable for the therapeutic area focused outcomes of medical activities, including project level budget and planning responsibilities.
Accountable for ensuring the development, delivery, and execution of the medical strategy and activities associated with launch readiness.
Creates an integrated, asset-focused culture within the TA by identifying and recruiting the right talent into roles and establishing accountability across clinical development, medical affairs strategy, and field-based medicine.
Ensures that the team is a responsive and trusted source of current medical practice, scientific expertise, and business acumen (e.g., disease states, product label, clinical trial interpretation, competitive landscape, barriers to implementation of guidelines into routine practice, etc.) for internal and external stakeholders.
Responsible for leading, managing the performance, and developing a team of both in-house and field-based professionals. Responsible for ensuring therapeutic area staff meets department goals and collaborate with key stakeholders / BI functions, in accordance with compliance and regulatory guidelines.